Genetic Technologies Limited
GENE
$0.765
-$0.015-1.92%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.84M | -1.84M | -2.09M | -2.10M | -2.10M |
| Total Depreciation and Amortization | 83.80K | 83.60K | 91.50K | 91.90K | 115.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -197.40K | -197.00K | 693.00K | 696.30K | 918.80K |
| Change in Net Operating Assets | 90.80K | 90.60K | -- | -- | -132.90K |
| Cash from Operations | -1.87M | -1.86M | -1.31M | -1.31M | -1.20M |
| Capital Expenditure | -1.60K | -1.60K | -9.20K | -9.20K | -4.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.80K | 9.70K | 38.50K | 38.70K | 37.40K |
| Cash from Investing | 8.20K | 8.20K | 29.30K | 29.50K | 32.60K |
| Total Debt Issued | 300.50K | 300.50K | -- | -- | -- |
| Total Debt Repaid | -88.00K | -88.00K | -86.40K | -86.40K | -85.00K |
| Issuance of Common Stock | 1.29M | 1.29M | -- | -- | 3.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.30K | -2.30K | -1.10K | -1.10K | -458.00K |
| Cash from Financing | 987.60K | 985.60K | -57.10K | -57.30K | 2.03M |
| Foreign Exchange rate Adjustments | -21.00K | -20.90K | -8.20K | -8.20K | 71.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -892.50K | -890.60K | -1.34M | -1.35M | 937.20K |
